Clinton Stewart
Affiliations: | Pharmaceutical Sciences | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Pharmacology, Molecular Biology, Neuroscience BiologyGoogle:
"Clinton Stewart"Mean distance: 26716.5
Children
Sign in to add trainee| Markos Leggas | grad student | 2004 | UTHSC |
| Yanli Zhuang | grad student | 2006 | UTHSC |
| Mohamed Elmeliegy | grad student | 2012 | UTHSC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Perkins RS, Davis A, Campagne O, et al. (2022) CNS penetration of methotrexate and its metabolite 7-hydroxymethotrexate in mice bearing orthotopic Group 3 medulloblastoma tumors and model-based simulations for children. Drug Metabolism and Pharmacokinetics. 100471 |
| Benzel J, Sauter M, Mack N, et al. (2020) Abstract A25: Evaluation of Drug Disposition in Supratentorial Ependymoma Cancer Research. 80 |
| Stewart C, Campagne O, Davis A, et al. (2019) CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 22: 612-629 |
| Campagne O, Davis A, Maharaj AR, et al. (2019) CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105106 |
| Jones Z, Roberts J, Houke H, et al. (2017) Abstract 314: Evaluation of effective drug combinations of sonidegib and ribociclib for treatment of Sonic hedgehog medulloblastoma using mathematical models of the cell cycle and Hedgehog pathways Cancer Research. 77: 314-314 |
| Morfouace M, Nimmervoll B, Boulos N, et al. (2015) Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors. Journal of Neuro-Oncology |
| Jacus MO, Daryani VM, Harstead KE, et al. (2015) Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature. Clinical Pharmacokinetics |
| Morfouace M, Cheepala S, Jackson S, et al. (2015) ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy. Cancer Research |
| Panetta JC, Baker SD, Kantarjian HM, et al. (2015) Population Pharmacokinetics of Crenolanib, a Type I FLT3 Inhibitor, in Patients with Relapsed/Refractory AML Blood. 126: 3695-3695 |
| Morfouace M, Patel Y, Shelat A, et al. (2015) Abstract IA21: Pediatric medulloblastoma: Drug screens and preclinical studies Brain. 75 |